Filing Details
- Accession Number:
- 0001209191-10-023593
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-04-26 13:00:00
- Reporting Period:
- 2010-04-23
- Filing Date:
- 2010-04-26
- Accepted Time:
- 2010-04-26 13:41:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1178670 | Alnylam Pharmaceuticals Inc. | ALNY | Pharmaceutical Preparations (2834) | 770602661 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1030617 | Ag Pharma Novartis | Lichstrasse 35 Basel Switzerland V8 CH 4002 | No | No | Yes | No | |
1114448 | Ag Novartis | Lichstrasse 35 Basel Switzerland V8 CH 4002 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-04-23 | 55,223 | $17.99 | 5,602,898 | No | 4 | P | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnote |
Footnotes
- These securities are owned directly by Novartis Pharma AG, a direct, wholly-owned subsidiary of Novartis AG. Novartis AG is an indirect beneficial owner of these securities.